Awakn Enters U.S. Addiction Treatment & Relapse Prevention Market With Ketamine Therapy For Alcohol Use Disorder
[ad_1] Awakn Life Sciences Corp. AWKNF, the biotech company focused on addiction treatments, has signed a licensing partnership agreement with US ketamine therapy clinics owner Revitalist Lifestyle and Wellness Ltd.…
Major Goals For ATAI: $175M Secured In Term Loan Facility, Plus Q2 Earnings Report
[ad_1] Clinical-stage psychedelics company ATAI Life Sciences N.V. ATAI announced its financial results for the quarter ended June 30, 2022 and business updates, including a term loan facility agreement for up…
Small Pharma Inc.’s New Clinical Study: Understanding The Interaction Of DMT-Assisted Therapy And SSRI Drugs
[ad_1] Short-acting psychedelics company Small Pharma Inc. DMTTF has received the approval from the U.K. Medicines and Healthcare products Regulatory Authority (MHRA) and the Regional Ethics Committee for a drug…
Oregon Psilocybin Services Act: State Vs. Local Decisions, The Ultimate ‘Opt-Out’ Choice
[ad_1] Oregon’s elected councilors in Philomath joined the debate on whether to offer their voters to “opt out” of Measure 109, the state-wide legalization project for the use of medical psilocybin.…
This Psychedelics Company Is Setting Up An Equity Program For Up To $35M In Shares
[ad_1] Cybin Inc. CYBN CYBN has launched an at-the-market (ATM) equity program through which it will issue and sell up to $35 million in common shares in the company’s capital, from the…
BREAKING: COMPASS Pathways Sued For Alleged Theft Of Psilocybin Trade Secrets
[ad_1] Terran Biosciences Inc. is suing COMPASS Pathways CMPS for the appropriation of trade secrets. Terran, a private biotech platform company filed a complaint against COMPASS last Friday. On Monday, August 8,…
Towards Ego Transcendence: Can VR Produce Experiences Similar To Those Of Psychedelics?
[ad_1] A recent research article assessing ego identity reduction and increased feelings of connectedness found key insights regarding a potentially similar response in people subjected to a VR experience than…
Meet The New Platform Educating On Safe & Regulated Access To Microdosing Psychedelics
[ad_1] As interest in psychedelics grows, the non-profit initiative titled Microdosing Collective has been launched to promote the regulated uses of psychedelics, supporting education around regulations to allow for legal,…
Red Light Holland Closes 2022 Fiscal Year, Shares Financial And Business Results
[ad_1] Red Light Holland Corp. TRUFF, the Ontario-based company engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America as well as…
San Francisco Legislators Introduce Resolution To Decriminalize Psychedelics
[ad_1] San Francisco lawmakers in California recently introduced a resolution aiming at locally deprioritizing law enforcement on the possession, use, cultivation and social sharing of naturally-occurring psychedelic substances like psilocybin,…
Irwin Naturals Acquires Third Ketamine Clinic, Steps Further Into New England Region
[ad_1] Plant-based medicine producer Irwin Naturals Inc. IWINF has purchased all the assets of New England Ketamine located in Salem, New Hampshire and serving patients in six states in the…
Psychedelics And The National Institutes Of Health—How Do They Relate?
[ad_1] As David Hodes first noted in The Green Market Report, the U.S. National Institutes of Health (NIH)’s growing interest in psychedelic studies is remarkable. The agency annually invests about $41.7…
New Zealand Government Grants $650K For LSD Microdosing Trials
[ad_1] Mindbio Therapeutics, a subsidiary of cannabis and psychedelics holding company Blackhawk Growth Corp. BLRZF, together with research collaborators at the University of Auckland, have received NZ$1.44 million ($650,000) in funding from…
Congress: Two New Bills Would Pressure The DEA To Allow Patient Access To Psychedelics And Marijuana
[ad_1] On July 20, bipartisan lawmakers from both chambers of Congress sent companion bills clarifying that federal Right to Try (RTT) laws give terminally-ill patients access to Schedule I substances including marijuana and…
Michael Pollan On The Late Show With Stephen Colbert: Past, Present And Future Of Psychedelics
[ad_1] Best-selling journalist and author Michael Pollan appeared live at The Late Show with Stephen Colbert on Thursday, on the heels of the Netflix release of How To Change Your Mind. “I…
Awakn’s Phase 3 Trial On Ketamine Therapy Gets Almost $2M From UK State Funding
[ad_1] Biotech psychedelics company Awakn Life Sciences Corp. AWKNF has been granted funding for 66% of the costs from its phase 3 clinical trial on ketamine therapy for alcohol use disorder…